CDC- BRFSS – ACBS 2020 Adult Prevalence Table 4
| State/Territory | Current | |||
|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | |
| Arizona | 314 | 28.9 | 4.5 | (20.1 – 37.7) |
| Connecticut | 297 | 29.2 | 4.1 | (21.2 – 37.2) |
| Florida | 283 | 30.0 | 5.3 | (19.6 – 40.4) |
| Georgia | 269 | 28.3 | 4.8 | (18.9 – 37.7) |
| Hawaii | 230 | 31.3 | 4.2 | (23.1 – 39.5) |
| Indiana | 287 | 39.8 | 4.1 | (31.8 – 47.8) |
| Iowa | 276 | 27.9 | 3.3 | (21.4 – 34.4) |
| Kansas | 225 | 27.5 | 4.1 | (19.5 – 35.5) |
| Maine | 384 | 28.0 | 4.1 | (20.0 – 36.0) |
| Maryland | 148 | 34.0 | 5.4 | (23.4 – 44.6) |
| Massachusetts | 230 | 30.2 | 4.1 | (22.2 – 38.2) |
| Michigan | 322 | 30.9 | 3.8 | (23.5 – 38.3) |
| Minnesota | 471 | 43.4 | 2.9 | (37.7 – 49.1) |
| Missouri | 253 | 37.6 | 4.9 | (28.0 – 47.2) |
| Montana | 236 | 25.1 | 3.9 | (17.5 – 32.7) |
| Nebraska | 422 | 38.4 | 3.6 | (31.3 – 45.5) |
| New Hampshire | 369 | 31.0 | 3.4 | (24.3 – 37.7) |
| New Jersey | 434 | 33.6 | 3.0 | (27.7 – 39.5) |
| New Mexico | 243 | 33.5 | 5.1 | (23.5 – 43.5) |
| New York | 178 | 32.0 | 5.0 | (22.2 – 41.8) |
| Ohio | 400 | 28.6 | 3.4 | (21.9 – 35.3) |
| Oregon | 229 | 27.5 | 3.7 | (20.2 – 34.8) |
| Pennsylvania | 175 | 39.1 | 5.7 | (27.9 – 50.3) |
| Rhode Island | 234 | 36.0 | 5.0 | (26.2 – 45.8) |
| Texas | 390 | 36.1 | 5.4 | (25.5 – 46.7) |
| Utah | 357 | 26.6 | 2.9 | (20.9 – 32.3) |
| Vermont | 376 | 37.8 | 3.8 | (30.4 – 45.2) |
| Wisconsin | 226 | 30.6 | 4.3 | (22.2 – 39.0) |
| Puerto Rico | 214 | 36.1 | 5.8 | (24.7 – 47.5) |
| 29 States / Area | 8,472 | 32.6 | 1.1 | (30.4 – 34.8) |
| Median | 31.0 | |||
| Range | 25.1-43.4 | |||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2020/pdf/sdq_report_acbs_20-508.pdf